- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Siemens enhances preclinical PET software
Other headlines:Barco lands contract with Italian mammography firmAmerinet expands Fujifilm offerings
Siemens enhances preclinical PET software
Siemens Healthcare will launch tomorrow at the SNM meeting in Toronto newly enhanced software for viewing data acquired on its Inveon preclinical PET scanner. The upgraded Inveon Research Workplace (IRW) offers an expanded tool set for image visualization and data analysis, as well as new tools for cardiac PET applications. IRW version 3.0 enables visualization and analysis of dual-gated dynamic PET data free from cardiac and respiratory motion artifacts, according to the company. The new software also allows for quick and accurate high-resolution image data export, representation, and interpretation, while delivering such features as arbitrary image reorientation and image filtering.
Barco lands contract with Italian mammography firm
Medical imaging specialist Barco will integrate newly available 20-inch LCD panels into mammography workstations under a supply contract signed with Bologna, Italy-based IMS (Internazionale Medico Scientifica). The MDRC-2120 panels, featuring a resolution of 1600 x 1200 pixels, will be part of IMS's Raffaello image acquisition workstations. MDRC-2120 shows digitally acquired images with better contrast and higher brightness, thanks to the high-quality LCD panel and preset DICOM lookup table, according to Barco.
Amerinet expands Fujifilm offerings
Group purchasing organization Amerinet has added Synapse cardiovascular and Synapse RIS to its existing Fujifilm contracts. With this addition, Amerinet members have access to the complete Fujifilm product portfolio, including PACS, digital x-ray, digital mammography, and film.
New CT Angiography Study Shows Impact of COVID-19 on Coronary Inflammation and Plaque
February 5th 2025Prior COVID-19 infection was associated with a 28 percent higher progression of total percent atheroma volume (PAV) annually and over a 5 percent higher incidence of high-risk plaque in patients with coronary artery lesions, according to CCTA findings from a new study.
